Growth Metrics

SELLAS Life Sciences Group (SLS) Long-Term Debt Issuances: 2011-2013

Historic Long-Term Debt Issuances for SELLAS Life Sciences Group (SLS) over the last 2 years, with Jun 2013 value amounting to $9.9 million.

  • SELLAS Life Sciences Group's Long-Term Debt Issuances rose 12.54% to $9.9 million in Q2 2013 from the same period last year, while for Jun 2013 it was $36.2 million, marking a year-over-year increase of 3.13%. This contributed to the annual value of $15.0 million for FY2016, which is N/A change from last year.
  • Per SELLAS Life Sciences Group's latest filing, its Long-Term Debt Issuances stood at $9.9 million for Q2 2013, which was up 12.54% from $8.8 million recorded in Q1 2013.
  • Over the past 5 years, SELLAS Life Sciences Group's Long-Term Debt Issuances peaked at $9.9 million during Q2 2013, and registered a low of $8.8 million during Q2 2011.
  • In the last 3 years, SELLAS Life Sciences Group's Long-Term Debt Issuances had a median value of $8.8 million in 2013 and averaged $8.9 million.
  • Data for SELLAS Life Sciences Group's Long-Term Debt Issuances shows a peak YoY climbed of 12.54% (in 2013) over the last 5 years.
  • Over the past 3 years, SELLAS Life Sciences Group's Long-Term Debt Issuances (Quarterly) stood at $8.8 million in 2011, then remained steady at $8.8 million in 2012, then increased by 12.54% to $9.9 million in 2013.
  • Its Long-Term Debt Issuances was $9.9 million in Q2 2013, compared to $8.8 million in Q1 2013 and $8.8 million in Q4 2012.